Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/18916
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAyati, Narjess-
dc.contributor.authorJesudason, Sarah-
dc.contributor.authorBerlangieri, Salvatore U-
dc.contributor.authorScott, Andrew M-
dc.date.accessioned2018-09-12T23:37:45Z-
dc.date.available2018-09-12T23:37:45Z-
dc.date.issued2017-
dc.identifier.citationAsia Oceania journal of nuclear medicine & biology 2017; 5(2): 148-150-
dc.identifier.issn2322-5718-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/18916-
dc.description.abstractWe report on a 59-year-old female patient with an infected vascular graft investigated with 18F FDG-PET/CT. The first of two studies showed FDG activity in the left deltoid and ipsilateral axillary lymph nodes explained by influenza vaccination the day prior. The second 18F FDG-PET/CT showed multiple FDG-avid lymph nodes on both sides of the diaphragm without tracer accumulation at the vaccination site. Three months later the CT was negative for lymphadenopathy within the chest or abdominal region. Although influenza vaccination is a potential source of false positive results in FDG PET studies, generalised lymph node activation post vaccination is a rare finding with only one prior published report in individuals infected with HIV-1. This case emphasizes the necessity of taking a history of vaccination prior to a FDG PET study, and consideration of a vaccine-related immune response even without evidence of tracer activity at the vaccination site when generalised FDG-avid lymphadenopathy is encountered.-
dc.language.isoeng-
dc.subject18F FDG-PET-
dc.subjectFalse positive-
dc.subjectImmunization-
dc.subjectInfluenza vaccination-
dc.subjectLymph node-
dc.titleGeneralized Lymph Node Activation after Influenza Vaccination on 18F FDG-PET/CT Imaging, an Important Pitfall in PET Interpretation.-
dc.typeJournal Article-
dc.identifier.journaltitleAsia Oceania journal of nuclear medicine & biology-
dc.identifier.affiliationDepartment of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Molecular Imaging & Therapy, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute; and School of Cancer Medicine, La Trobe University, Australiaen
dc.identifier.affiliationNuclear medicine Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran..-
dc.identifier.doi10.22038/aojnmb.2017.8702-
dc.identifier.orcid0000-0002-6656-295X-
dc.identifier.pubmedid28660226-
dc.type.austinJournal Article-
local.name.researcherAyati, Narjess
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.grantfulltextnone-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptClinical Haematology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

30
checked on Jun 14, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.